… Due to the non-availability of any vaccine or drugs against COVID-19, immunotherapies
involving convalescent plasma, immunoglobulins, antibodies (monoclonal or polyclonal), and …

The COVID-19 pandemic has forced all of us to change … in cancer immunology and
immunotherapy with the scientific … immunity and immunotherapy beyond the COVID-19 pandemic.” …

… The pandemic of coronavirus disease 2019 (COVID-19) … from person to person among
COVID-19 patients, but on average … Antibodies in COVID-19 patients are derived from broad and …

… plasma therapy (CPT) or passive immunotherapy (PIT), which has recently … COVID-19 (coronavirus
infection disease 2019) patients. Citation11 CPT is a classic adaptive immunotherapy …

… immunotherapeutic development in respiratory infections because of its presence on respiratory
tract epithelium; for this reason, it has been proposed as a candidate target in COVID-19 …

… the immunobiology of SARS-CoV-2, while mitigating further spread of this deadly pathogen.
… the Coronavirus Disease 2019 (COVID-19). The clinical manifestations of COVID-19 form a …

… efficacy and safety of a passive immunotherapy strategy using hyperimmune equine serum
… patients with COVID-19, in patients with severe acute respiratory syndrome coronavirus 2 (…

… 2 vaccine development, COVID-19 therapy remains challenging. … COVID-19 have been
extensively discussed. Here, we reviewed the roles of immunomodulation as potential COVID-19 …

… To identify studies reporting on immunological responses to COVID-19 vaccines in patients
with cancer, we searched PubMed for articles published in English between Jan 1 and Dec 1…

… Although the association between asthma and COVID-19 has been under investigation,
immunobiological treatment should follow the consensus-based statements recommending the …